CIMT Versus HABIT in Late Sub-Acute Post-Stroke Rehabilitation (NCT07626554) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
CIMT Versus HABIT in Late Sub-Acute Post-Stroke Rehabilitation
Pakistan34 participantsStarted 2025-06-05
Plain-language summary
This study will compare the effects of Constraint Induced Movement Therapy and Hand-Arm Bimanual Intensive Training on upper extremity function in late sub-acute post-stroke patients. It will be a randomized controlled trial. Eligible participants will be randomly allocated into two groups. One group will receive Constraint Induced Movement Therapy, while the other group will receive Hand-Arm Bimanual Intensive Training. Both groups will also receive standard physiotherapy for mobility and postural control. The intervention will continue for 3 weeks. Outcomes will be assessed at baseline and after the intervention using upper limb function and motor control assessment tools.
Who can participate
Age range
40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Adults aged 40 years and above.
* Diagnosed with unilateral ischemic or hemorrhagic stroke.
* Stroke duration between 3 to 6 months.
* Mini-Mental State Examination score of 24 or above.
* Able and willing to provide informed consent.
Exclusion Criteria:
Severe pain in the more affected upper limb on verbal rating scale.
* Spasticity greater than 3 on the Modified Ashworth Scale in the affected upper limb.
* Unstable cardiovascular conditions.
* Any traumatic musculoskeletal injury of the upper limb.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Fugl-Meyer Assessment - Upper Extremity (FMA-UE)
Timeframe: Baseline and Week 3 (Post-intervention)
2
Action Research Arm Test (ARAT)
Timeframe: Baseline and Week 3 (Post-intervention)